Related Experiment Video
Updated: Feb 17, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiR-124 Inhibits Growth and Enhances Radiation-Induced Apoptosis in Non-Small Cell Lung Cancer by Inhibiting STAT3
Mengjie Wang1,2, Bi Meng1,2, Yangchen Liu2
1Bengbu Medical School, Bengbu, China.
Background/Aims:
A growing body of evidence indicates that the abnormal expression of microRNAs (miRNAs) play an important role in sensitizing the cellular response to ionizing radiation (IR). The aim of this study was to investigate whether the expression of miR-124 correlated with radiosensitivity in the context of non-small-cell lung carcinoma (NSCLC).
Methods:
Quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to quantify miR-124 expression in NSCLC tissues and cell lines. The role of miR-124 in NSCLC proliferation and radiosensitivity was analyzed using CCK-8 and flow cytometry apoptosis assays. Luciferase activity assays, RT-PCR, and Western blot assays were performed to confirm the target gene of miR-124.
Results:
In this study, we found that miR-124 was downregulated both in clinical NSCLC samples and in cell lines. miR-124 inhibited the proliferation of NSCLC cells and enhanced the apoptosis of NSCLC cells exposed to ionizing radiation. We identified signal transducer and activator of transcription 3 (STAT3) as a direct target of miR-124 by using target prediction algorithms and luciferase assays. Overexpression of STAT3 in A549 cell lines restored the enhanced radiosensitivity induced by miR-124.
Conclusion:
Taking these observations into consideration, we illustrated that miR-124 is a potential target for enhancing the radiosensitivity of NSCLC cells by targeting STAT3.
Insights
MicroRNA-124 (miR-124) is downregulated in non-small-cell lung carcinoma (NSCLC) and enhances radiosensitivity by targeting STAT3. Restoring miR-124 may improve radiation therapy for NSCLC patients.
Area of Science:
- Molecular Biology
- Oncology
- Radiotherapy Research
Background:
- MicroRNAs (miRNAs) are increasingly recognized for their role in cellular responses to ionizing radiation (IR).
- Abnormal miRNA expression is implicated in cancer development and treatment resistance.
- Non-small-cell lung carcinoma (NSCLC) radiosensitivity is a critical factor in treatment outcomes.
Purpose of the Study:
- To investigate the correlation between miR-124 expression and radiosensitivity in NSCLC.
- To elucidate the molecular mechanisms underlying miR-124's effect on NSCLC radiosensitivity.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (RT-PCR) for miR-124 expression analysis.
- Cell proliferation (CCK-8) and apoptosis assays (flow cytometry) to assess miR-124 function.
- Luciferase activity, RT-PCR, and Western blot assays to identify and validate miR-124 targets.
Main Results:
- miR-124 was significantly downregulated in NSCLC tissues and cell lines.
- miR-124 suppressed NSCLC cell proliferation and promoted apoptosis following ionizing radiation exposure.
- Signal transducer and activator of transcription 3 (STAT3) was identified as a direct target of miR-124.
- STAT3 overexpression reversed the radiosensitizing effects of miR-124 in NSCLC cells.
Conclusions:
- miR-124 plays a crucial role in regulating NSCLC radiosensitivity.
- Targeting STAT3 by miR-124 offers a potential therapeutic strategy to enhance radiosensitivity in NSCLC.
- miR-124 represents a promising biomarker and therapeutic target for improving radiation therapy efficacy in NSCLC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

